Louis J Aronne

17PUBLICATIONS
55CO-AUTHORS
Food properties (incl. characteristics and health benefits)PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 12, 2026
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial.

|Apr 19, 2026
Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5.

|Mar 25, 2026
Monlunabant in adults with obesity and metabolic syndrome: Open-label extension of a phase 2a trial.

Filip K Knop, George Kunos, Dror Dicker

|Mar 02, 2026
Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial.

Steven B Heymsfield, Louis J Aronne, Penelope Montgomery

|Feb 25, 2026
The important role of comorbidities in the management of obesity.

Sarah R Barenbaum, Beverly G Tchang, Louis J Aronne

|Feb 04, 2026
A treat-to-target approach for obesity management: A post hoc analysis of the SURMOUNT-5 trial.

Carel W le Roux, Luca Busetto, Louis Aronne

Pageof 3

Frequent Collaborators

3 joint publications

Carel W le Roux

3 joint publications

Julia P Dunn

2 joint publications

Sarah R Barenbaum

2 joint publications

Beverly G Tchang